Search

everythinglearnresearchcommunity

for

Search:↓

Myo-inositol helps improve skin conditions and metabolic profiles in young women with PCOS.

Some drugs can cause hair loss, and stopping these drugs often leads to hair regrowth.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Women with PCOS often experience anxiety, depression, and a lower quality of life.

Fadrozole and finasteride change gene expression related to sex hormones and thyroid hormones in frog larvae development.

Metformin combined with lifestyle changes improves insulin resistance and reduces testosterone levels in women with PCOS more than lifestyle changes alone.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

Some dermatological medications can impair male fertility, so consult a doctor before trying to conceive.

Lifestyle changes and weight loss are key for treating PCOS-related metabolic issues and infertility, with various medications available for specific symptoms.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

South Asian women with PCOS experience more psychological distress and have a poorer quality of life, especially in social relationships, with hirsutism affecting them more than obesity.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

Melatonin improved mental health and metabolism in women with PCOS.

Women with PCOS often have mood disorders and a lower quality of life, and treatment should focus on both physical and mental health.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Rutin may help treat symptoms of polycystic ovary syndrome (PCOS) in rats.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Gene therapy has potential as a future treatment for Hutchinson-Gilford progeria syndrome.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Natural molecules like inositols, resveratrol, vitamins, and omega-3 fatty acids may help manage Polycystic Ovary Syndrome (PCOS), but their effects vary and need more exploration.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

A male with aromatase deficiency improved bone health with estradiol treatment.

The conclusion is that formalizing how past decisions influence current health technology assessments could improve the credibility and defense of coverage decisions.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Brazilian women with PCOS and both menstrual irregularity and high male hormone levels have a higher chance of having metabolic syndrome.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

The conclusion is that CD90 is not a specific marker for fibroblast subtypes and better methods are needed to identify them.